See also this year's filing and all EDGAR filings for this company.
PDF Report 0001590750_2024_Viridian_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001590750, Viridian Therapeutics Inc DE
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 2,274,000 |
| 2 | AssetsCurrent | 486,478,000 |
| 3 | PropertyPlantAndEquipment | 1,672,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 989,000 |
| 6 | LiabilitiesCurrent | 26,635,000 |
| 7 | remainder_Liabilities | 20,778,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 94,999,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 159,765,000 |
| 17 | remainder_Revenues | 314,000 |
| 18 | remainder_NetIncome | 16,716,000 |
| 19 | remainder_ComprehensiveNetIncome | 728,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 490,424,000 |
| 1 | Liabilities | 48,402,000 |
| 2 | Expenses | 254,764,000 |
| 3 | Revenues | 314,000 |
| 4 | StockholdersEquity | 442,022,000 |
| 5 | NetIncome | -237,734,000 |
| 6 | ComprehensiveNetIncome | -237,006,000 |
| 7 | BaseVar | 405,674,000 |
| 8 | EconomicCapitalRatio | 3.68 |
Edgar->Model Mapping
Feature Distribution
Change over Time
